• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用不同菌株和物种的利什曼原虫灭活前鞭毛体对C57BL/10小鼠进行皮肤利什曼病疫苗接种。

Vaccination of C57BL/10 mice against cutaneous Leishmaniasis using killed promastigotes of different strains and species of Leishmania.

作者信息

Mayrink Wilson, Santos Gilmara Cristina dos, Toledo Vicente de Paulo Coelho Peixoto de, Guimaraes Tânia Mara Pinto Dabés, Machado-Coelho George Luis Lins, Genaro Odair, da Costa Carlos Alberto

机构信息

Departamento de Parasitologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, MG.

出版信息

Rev Soc Bras Med Trop. 2002 Mar-Apr;35(2):125-32. doi: 10.1590/s0037-86822002000200001.

DOI:10.1590/s0037-86822002000200001
PMID:12011920
Abstract

Antigenic extracts from five Leishmania stocks were used to vaccinate C57BL/10 mice. The Leishvacin(R) and PH8 monovalent vaccine yielded the highest IFN-gamma levels in the supernatants of spleen cell culture from vaccinated animals. Each single strain immunized group showed evidence of protective immunity six months after the challenge with promastigotes of Leishmania (Leishmania) amazonensis. No differences were detected between the vaccinated groups. It can be concluded that vaccines composed of single Leishmania stocks can provide protection to C57BL/10 mice against L. (L.) amazonensis infection.

摘要

用来自五种利什曼原虫株的抗原提取物对C57BL/10小鼠进行免疫接种。Leishvacin(R)和PH8单价疫苗在免疫动物脾细胞培养上清液中产生的干扰素-γ水平最高。在用亚马逊利什曼原虫(利什曼原虫属)前鞭毛体攻击六个月后,每个单菌株免疫组均显示出保护性免疫的证据。免疫组之间未检测到差异。可以得出结论,由单一利什曼原虫株组成的疫苗可以为C57BL/10小鼠提供针对亚马逊利什曼原虫感染的保护。

相似文献

1
Vaccination of C57BL/10 mice against cutaneous Leishmaniasis using killed promastigotes of different strains and species of Leishmania.使用不同菌株和物种的利什曼原虫灭活前鞭毛体对C57BL/10小鼠进行皮肤利什曼病疫苗接种。
Rev Soc Bras Med Trop. 2002 Mar-Apr;35(2):125-32. doi: 10.1590/s0037-86822002000200001.
2
Vaccine-induced protection against Leishmania amazonensis is obtained in the absence of IL-12/23p40.在缺乏白细胞介素-12/23 p40的情况下,可获得疫苗诱导的针对亚马逊利什曼原虫的保护作用。
Immunol Lett. 2006 May 15;105(1):38-47. doi: 10.1016/j.imlet.2005.12.002. Epub 2006 Jan 13.
3
Protection of C57BL/10 mice by vaccination with association of purified proteins from Leishmania (Leishmania) amazonensis.用来自亚马逊利什曼原虫(利什曼原虫)的纯化蛋白联合疫苗接种对C57BL/10小鼠进行保护。
Rev Inst Med Trop Sao Paulo. 1999 Jul-Aug;41(4):243-8. doi: 10.1590/s0036-46651999000400008.
4
Immune responses induced by a Leishmania (Leishmania) amazonensis recombinant antigen in mice and lymphocytes from vaccinated subjects.亚马逊利什曼原虫重组抗原在小鼠及接种疫苗受试者淋巴细胞中诱导的免疫反应。
Rev Inst Med Trop Sao Paulo. 1997 Mar-Apr;39(2):71-8. doi: 10.1590/s0036-46651997000200002.
5
Short-term protection conferred by Leishvacin® against experimental Leishmania amazonensis infection in C57BL/6 mice.利什瓦辛(Leishvacin®)对C57BL/6小鼠实验性亚马逊利什曼原虫感染的短期保护作用。
Parasitol Int. 2014 Dec;63(6):826-34. doi: 10.1016/j.parint.2014.07.010. Epub 2014 Aug 4.
6
Efficacy of vaccination with a combination of Leishmania amastigote antigens and the lipid A-analogue ONO-4007 for immunoprophylaxis and immunotherapy against Leishmania amazonensis infection in a murine model of New World cutaneous leishmaniasis.在新世界皮肤利什曼病的小鼠模型中,利什曼原虫无鞭毛体抗原与脂多糖类似物ONO - 4007联合疫苗接种对亚马逊利什曼原虫感染进行免疫预防和免疫治疗的效果。
Vaccine. 2006 Jul 7;24(27-28):5645-52. doi: 10.1016/j.vaccine.2006.03.023. Epub 2006 Mar 29.
7
Efficacy of intranasal LaAg vaccine against Leishmania amazonensis infection in partially resistant C57Bl/6 mice.鼻内接种LaAg疫苗对部分抗性C57Bl/6小鼠亚马逊利什曼原虫感染的疗效。
Parasit Vectors. 2016 Oct 6;9(1):534. doi: 10.1186/s13071-016-1822-9.
8
Immune responses and protection induced in mice by an industrialized vaccine against American cutaneous leishmaniasis.一种工业化的抗美洲皮肤利什曼病疫苗在小鼠体内诱导的免疫反应和保护作用。
Parassitologia. 1992 Dec;34(1-3):45-51.
9
The potency and durability of DNA- and protein-based vaccines against Leishmania major evaluated using low-dose, intradermal challenge.使用低剂量皮内攻击法评估基于DNA和蛋白质的针对硕大利什曼原虫疫苗的效力和持久性。
J Immunol. 2001 Apr 15;166(8):5122-8. doi: 10.4049/jimmunol.166.8.5122.
10
Interferon-gamma-inducing oral vaccination with Leishmania amazonensis antigens protects BALB/c and C57BL/6 mice against cutaneous leishmaniasis.用亚马逊利什曼原虫抗原进行诱导γ干扰素的口服疫苗接种可保护BALB/c和C57BL/6小鼠免受皮肤利什曼病感染。
Vaccine. 2003 Sep 8;21(25-26):3534-41. doi: 10.1016/s0264-410x(03)00427-4.

引用本文的文献

1
MPLA and AddaVax Adjuvants Fail to Promote Intramuscular LaAg Vaccine Protectiveness against Experimental Cutaneous Leishmaniasis.MPLA和AddaVax佐剂未能增强肌肉注射LaAg疫苗对实验性皮肤利什曼病的保护作用。
Microorganisms. 2021 Jun 11;9(6):1272. doi: 10.3390/microorganisms9061272.
2
Leishmaniasis in humans: drug or vaccine therapy?人类利什曼病:药物治疗还是疫苗治疗?
Drug Des Devel Ther. 2017 Dec 22;12:25-40. doi: 10.2147/DDDT.S146521. eCollection 2018.